R2B Strategy
Innovate from a Market Perspective Not Technology
Research to Business
Innovate from a Market Perspective Not Technology
The seeds of innovation emerge from unexpected combinations of differing technologies and differing fields.
In Kaneka’s R2B, the R2B system is maintained while constantly making improvements from the standpoint of increasing opportunities for these differing people and things to meet.
R2B＋P System Generates Innovation
Since 2024, all 12 R2B laboratories form a system, and we firmly established an R2B system for business fields of the Solutions Unit. In particular, for issues of importance requiring speed, we work to respond as appropriate by creating a project system.
R2B Laboratories Network
R2B Conducted via a Hybrid System
Accelerating the Societal Implementation of Green Planet™
Kaneka biodegradable polymer Green Planet™ is made from 100% biomass and has high biodegradability, so there is strong market need for it as a product that contributes to solving environmental issues. A large coffee chain adopting it for their straws was major news.
In R2B, along with high-efficiency cultivation and production technologies, the development of advanced mold processing technologies is being conducted on a company-wide basis centering on Green Planet Technology Laboratories.
In fiscal 2024, application development is also expanding, including adoption of foam molding products. Going forward, business will expand through the development of new applications.
BRAVIA™ packaging materials using Green Planet™ and image of use
“BRAVIA™” is a registered trademark or trademark of Sony Group Corporation or its affiliates.
CO2 Usage Technologies for the Future
We are developing future technologies that directly use CO2 as a raw material as we strive to reduce environmental impact. Technology for producing Green Planet™ using CO2 as a raw material is set to be used in bench equipment, with operations slated for fiscal 2025.
Moreover, we are developing biomanufacturing technologies and are also conducting R2B to create new markets through hybrids with our health and food product technologies.
Innovate from a Market Perspective Not Technology
